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Reply to Barbujani et al.
To the Editor:
We agree entirely with Barbujani et al. (1998 [in this
issue]) that the age of a group of haplotypes cannot be
mechanically equated to the age of the population from
which they come and that such an uncritical equation
would artificially elevate the estimated age of the pop-
ulation under study. However, our analysis (Richards et
al. 1996, p. 194) focuses not simply on haplogroups,
but on haplotypes within haplogroups. Such an analysis
depends critically on the correct identification—by cross-
population comparison of lineages—of all of the major
founder haplotypes, which can then be used as a baseline
from which to date the founder events associated with
each cluster of haplotypes. This is exemplified in our
paper by the identification of a number of distinct foun-
der haplotypes in lineage group 2A, picked out on the
basis of their presence as shared ancestral nodes in the
European and Near Eastern phylogenies, which root
deeply (during the Upper Paleolithic period) in the Near
Eastern data but which have accumulated only a small
amount of variation—equivalent to ∼10,000 years or
so—within Europe. This suggests, to us, expansion into
Europe from the Near East during the Neolithic period.
Of the various lineage clusters that we identified in Eu-
rope and the Near East, only group 2A showed this
pattern; other clusters did not show evidence of recent
founder events within Europe.
We believe that a phylogeographic analysis such as
this—which is indeed based on molecules rather than
on populations—is capable of a much finer resolution
than one based on distance statistics, such as that sug-
gested by Barbujani et al. (1998). Moreover, the partic-
ular statistic used is misleading, as it is based on a model
of populations of constant size at mutation-drift equi-
librium, which is patently unsuitable for application to
Europe and the Near East. However, an important weak-
ness of our published analysis is the meager volume of
comparative data from the Near East: essentially 42 in-
dividuals, mostly from the Arabian peninsula. In sub-
sequent work, we are extending the analysis to a much
larger sample from southwestern Asia, to improve our
confidence that most founder haplotypes have been iden-
tified. We aim to report our conclusions in the near
future.
MARTIN RICHARDS AND BRYAN SYKES
Department of Cellular Science
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Reply to Hofmann et al.
To the Editor:
In the June issue of the Journal, Hofmann et al. (1997)
commented on our study of Leber hereditary optic neu-
ropathy (LHON; MIM 535000 [http://www3.ncbi
.nlm.nih.gov:80/htbin-post/Omim/dispmim?535000])
multigeneration pedigrees (Mackey et al. 1996). Hof-
mann et al. made two main points in their letter, the first
of which was that a mutation at nucleotide 15257 of
the mitochondrial cytochrome b gene has a pathogenic
role in LHON. This is a long-standing and unresolved
controversy that epitomizes the pitfalls that beset the
identification of pathogenic mtDNA mutations. Their
second point, which is not an issue that we addressed,
was that “so-called” secondary LHON mutations, in
their terminology, play an etiologic role in other neu-
rological disorders.
There is broad agreement that mtDNA mutations at
nucleotides 3460, 11778, and 14484 are pathogenic
LHON mutations, but there is disagreement over the
pathogenic role of the 15257 mutation (Howell 1994,
1997a; Oostra et al. 1994). In our previous reports, in-
cluding that by Mackey et al. (1996), the term “primary”
was applied to the 3460, 11778, and 14484 LHON
mutations. LHON is maternally inherited, but the pen-
etrance is incomplete. The pathogenic mtDNA mutation
is thus the predominant risk factor, but additional eti-
ologic factors are required for manifestation of the optic
neuropathy (Howell et al. 1997a, 1997b). In that sense,
the 3460, 11778, and 14484 mtDNA mutations have a
primary pathogenic role in LHON. Several additional
mtDNA mutations have been identified that may have
an etiologic or pathogenic role in LHON, including some
that may augment or modify the phenotypic effects of
the three known pathogenic mutations (see below). As
a result of this uncertainty, the nomenclature has become
commensurately more complicated. For example, Brown
and Wallace (1994) list 16 mutations that have primary,
secondary, or intermediate roles in LHON, although
even this list is now incomplete (e.g., see Howell et al.
1998, and references therein).
The purpose of our previous study (Mackey et al.
1996) was to identify the pathogenic mtDNA mutations
in LHON pedigrees. A total of 159 families (comprising
∼12,000 maternal relatives) from Australia and northern
Europe were analyzed, because these are countries where
extensive genealogies are more easily obtained. We lim-
ited our study to large multigeneration LHON families,
to avoid the ambiguities that arise with singleton cases
of bilateral optic neuropathy in which maternal inher-
itance is lacking. The majority of sporadic cases of a
LHON-like optic atrophy are not associated with the
3460, 11778, or 14484 LHON mutations (Chan et al.
1996). None of these 159 LHON families carried the
15257 mutation in the absence of one of the three pre-
viously established LHON mutations, although it was
associated with one of the three mutations in six LHON
families. This association has also been found in other
LHON families (Howell et al. 1993; Oostra et al. 1994),
as well as among those analyzed by Hofmann et al.
(1997). The penetrance of pathogenic mutations is not
increased in the LHON families whose mtDNAs also
harbor the 15257 mutation (e.g., see Howell et al. 1993;
Torroni et al. 1997). These negative results argue against
a pathogenic role for the 15257 mutation, because
LHON is a disorder whose penetrance is particularly
dependent on the action of secondary etiologic factors
(Howell 1997a, 1997b).
In contrast to our results, Obermaier-Kusser et al.
(1994) reported a LHON family, with multiple affected
family members that span multiple generations, that car-
ries the 15257 mutation but not one of the three pre-
viously identified pathogenic LHON mutations. Hof-
mann et al. (1997) report a total of 55 optic neuropathy
index cases, 3 of which are 15257 plus 11778 and 6 of
which are 15257 plus 14484, but 5 of which are “15257
only.” It is not clear whether these 15257-only cases are
distant relatives of the LHON family described else-
where (Obermaier-Kusser et al. 1994) or have affected
maternal relatives. It is precisely because of the experi-
mental and analytical difficulties inherent to singleton
cases that we undertook our study of multigeneration
families. More important, sequencing analysis has not
been performed, either for the 15257-only LHON family
or for the new 15257 cases, and the presence of a rare,
unidentified pathogenic mutation cannot be ruled out.
The 15257 mutation has been detected at a low fre-
quency (Brown et al. 1992; Kalman et al. 1995; and
especially see Torroni et al. 1997) in normal control
subjects, a result that argues against a pathogenic role.
However, population surveys of normal controls should
capture individuals who harbor a pathogenic LHON
mutation but who, because of the incomplete pene-
trance, are not clinically affected. The 3460, 11778, and
